Literature DB >> 21196239

Vasculogenensis, angiogenesis and special features of tumor blood vessels.

Sachie Hiratsuka1.   

Abstract

The circulatory system comprises a tubular network of blood vessels including arterioles, capillaries, venules, and lymphatic vessels. This circulatory system is essential for the embryonic development and maintenance of all tissues, which requires the transportation of oxygen, carbon dioxide, and nutrition. The system regulates the movement of fluid into and out of organs with high level of efficiency. "Tumor angiogenesis" describes the rapid growth of certain components of the circulatory system in an abnormal fashion that is both heterogeneous and dysregulated. The aberrant flow between abnormal tumor vessels and normal vessels poses a high risk for seeding of potentially metastatic cancer cells. Moreover, it has also been reported that premetastatic distant organ vessels already undergo specific changes due to the presence of a remote primary tumor. Therapeutic strategies aimed at targeting tumor vessels have the potential to suppress tumor growth, and also influence the effects of tumor-derived cytokines and circulating tumor cells. Furthermore, focusing on vessels in a premetastatic organ that have responded to a primary tumor may be one possibility for reducing metastatic risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196239     DOI: 10.2741/3796

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  15 in total

Review 1.  Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?

Authors:  Martha L Arango-Rodriguez; Fernando Ezquer; Marcelo Ezquer; Paulette Conget
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

2.  Adhesion of small cell lung cancer cells to E- and P-selectin under physiological flow conditions: implications for metastasis formation.

Authors:  Ulrich Richter; Christine Schröder; Daniel Wicklein; Tobias Lange; Silvana Geleff; Virginia Dippel; Udo Schumacher; Susanne Klutmann
Journal:  Histochem Cell Biol       Date:  2011-03-29       Impact factor: 4.304

3.  An Improved In Vivo Methodology to Visualise Tumour Induced Changes in Vasculature Using the Chick Chorionic Allantoic Membrane Assay.

Authors:  Naside Mangir; Ahtasham Raza; John W Haycock; Christopher Chapple; Sheila Macneil
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

4.  Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies.

Authors:  Stacey D Finley; Marianne O Engel-Stefanini; P I Imoukhuede; Aleksander S Popel
Journal:  BMC Syst Biol       Date:  2011-11-21

5.  Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology.

Authors:  Ye Zhang; Jian-Zhong Wu; Jun-Ying Zhang; Jing Xue; Rong Ma; Hai-Xia Cao; Ji-Feng Feng
Journal:  Oncol Lett       Date:  2013-11-29       Impact factor: 2.967

6.  Endothelial hypoxic metabolism in carcinogenesis and dissemination: HIF-A isoforms are a NO metastatic phenomenon.

Authors:  Cristina Branco-Price; Colin E Evans; Randall S Johnson
Journal:  Oncotarget       Date:  2013-12

7.  Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts.

Authors:  Princess I Imoukhuede; Aleksander S Popel
Journal:  Cancer Med       Date:  2014-01-22       Impact factor: 4.452

8.  Effect of hypoxia on hypoxia inducible factor-1α, insulin-like growth factor I and vascular endothelial growth factor expression in hepatocellular carcinoma HepG2 cells.

Authors:  Qiang Liu; Zheng Xu; Shunbao Mao; Wenyou Chen; Rongyao Zeng; Song Zhou; Jing Liu
Journal:  Oncol Lett       Date:  2015-01-15       Impact factor: 2.967

9.  Bone marrow derived cells in adult skeletal muscle tissue in humans.

Authors:  Anna Strömberg; Monika Jansson; Helene Fischer; Eric Rullman; Hans Hägglund; Thomas Gustafsson
Journal:  Skelet Muscle       Date:  2013-05-16       Impact factor: 4.912

10.  Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci.

Authors:  Sachie Hiratsuka; Sachie Ishibashi; Takeshi Tomita; Akira Watanabe; Sachiko Akashi-Takamura; Masato Murakami; Hiroshi Kijima; Kensuke Miyake; Hiroyuki Aburatani; Yoshiro Maru
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.